Illumina Inc (NASDAQ:ILMN)

319.58
Delayed Data
As of Jan 24
 -7.42 / -2.27%
Today’s Change
263.30
Today|||52-Week Range
380.76
-3.67%
Year-to-Date
Better Buy: Exact Sciences vs. Qiagen
Jan 23 / MotleyFool.com - Paid Partner Content
Illumina and Roche Combine For Genomics Oncology Deal
Jan 14 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close327.00
Today’s open327.72
Day’s range318.28 - 328.31
Volume1,070,289
Average volume (3 months)918,839
Market cap$47.6B
Data as of 4:00pm ET, 01/24/2020

Growth & Valuation

Earnings growth (last year)+13.15%
Earnings growth (this year)+12.89%
Earnings growth (next 5 years)+18.65%
Revenue growth (last year)+21.11%
P/E ratio48.9
Price/Sales13.33
Price/Book12.68

Competitors

 Today’s
change
Today’s
% change
BIIBBiogen-6.07-2.14%
BMRNBiomarin Pharmaceuti...+0.52+0.61%
GILDGilead Sciences-0.79-1.24%
EXASExact Sciences Corp-2.61-2.83%
Data as of 4:00pm ET, 01/24/2020

Financials

Next reporting dateJanuary 30, 2020
EPS forecast (this quarter)$1.58
Annual revenue (last year)$3.3B
Annual profit (last year)$826.0M
Net profit margin24.78%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
San Diego, California

Forecasts